This is where the once-weekly injectable system shines
Here are several important considerations to keep in mind: FDA Approval : Currently, Tirzepatide (Mounjaro) is FDA-approved for the treatment of Type 2 diabetes, not specifically for weight loss
Studies show improved mental function
Patients experiencing substantial weight loss on Ozempic who are also taking levothyroxine should consider having their TSH levels rechecked, as weight loss can reduce levothyroxine requirements in some cases
The dose titration period is critical: Orforglipron is initiated at a low dose and titrated upward over several weeks, similar to injectable GLP-1 therapies
There's one catch: Consumers can only order the new vials by paying out of pocket via LillyDirect, a company platform that coordinates telehealth services and fills prescriptions for patients, the company said in a statement